Molecular pathways linking metabolic inflammation and thermogenesis

Obesity Reviews

Volumn 13, Issue SUPPL.2, 2012, Pages 69-82

  Solinas, G ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Cytokines; IKK; JNK; MAPK; PI3K

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; DOUBLE STRANDED RNA; I KAPPA B KINASE BETA; I KAPPA B KINASE BETA KINASE EPSILON; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PYROGEN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHRONIC DISEASE; DISEASE ASSOCIATION; ENERGY BALANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; METABOLIC DISORDER; MODULATION; MOLECULAR BIOLOGY; NONHUMAN; SIGNAL TRANSDUCTION; THERMOGENESIS;

ANIMALS; CYTOKINES; ENERGY METABOLISM; HUMANS; INFLAMMATION; OBESITY; SIGNAL TRANSDUCTION; THERMOGENESIS;

EID: 84868147961     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2012.01047.x     Document Type: Article

References (145)

1. Rothwell NJ, Stock MJ. Regulation of energy balance. Annu Rev Nutr 1981; 1: 235-256.
2. Stock MJ. Gluttony and thermogenesis revisited. Int J Obes Relat Metab Disord 1999; 23: 1105-1117.
3. Rothwell NJ. CNS regulation of thermogenesis. Crit Rev Neurobiol 1994; 8: 1-10.
4. Bachman ES, Dhillon H, Zhang CY etal. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002; 297: 843-845.
5. Jimenez M, Leger B, Canola K etal. Beta(1)/beta(2)/beta(3)-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting. FEBS Lett 2002; 530: 37-40.
6. Lowell BB, Bachman ES. Beta-Adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem 2003; 278: 29385-29388.
7. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 2000; 404: 652-660.
8. Young JB, Weiss J, Boufath N. Effects of dietary monosaccharides on sympathetic nervous system activity in adipose tissues of male rats. Diabetes 2004; 53: 1271-1278.
9. Landsberg L, Saville ME, Young JB. Sympathoadrenal system and regulation of thermogenesis. Am J Physiol 1984; 247: E181-E189.
10. Young JB, Landsberg L. Diminished sympathetic nervous system activity in genetically obese (ob/ob) mouse. Am J Physiol 1983; 245: E148-E154.
11. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996; 380: 677.
12. Trayhurn P, Jones PM, McGuckin MM, Goodbody AE. Effects of overfeeding on energy balance and brown fat thermogenesis in obese (ob/ob) mice. Nature 1982; 295: 323-325.
13. Trayhurn P, James WP. Thermoregulation and non-shivering thermogenesis in the genetically obese (ob/ob) mouse. Pflugers Arch 1978; 373: 189-193.
14. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5: 575-581.
15. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
16. Bergquist J, Tarkowski A, Ekman R, Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A 1994; 91: 12912-12916.
17. Flierl MA, Rittirsch D, Nadeau BA etal. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007; 449: 721-725.
18. Arsenijevic D, Onuma H, Pecqueur C etal. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000; 26: 435-439.
19. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 2004; 10: 201-222.
20. Leon LR. Cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol 2002; 92: 2648-2655.
21. Saper CB. Neurobiological basis of fever. Ann N Y Acad Sci 1998; 856: 90-94.
22. Luheshi GN. Cytokines and fever. Mechanisms and sites of action. Ann N Y Acad Sci 1998; 856: 83-89.
23. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006; 311: 1-16.
24. Li S, Ballou LR, Morham SG, Blatteis CM. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res 2001; 910: 163-173.
25. Li S, Wang Y, Matsumura K, Ballou LR, Morham SG, Blatteis CM. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice. Brain Res 1999; 825: 86-94.
26. Jepson MM, Millward DJ, Rothwell NJ, Stock MJ. Involvement of sympathetic nervous system and brown fat in endotoxin-induced fever in rats. Am J Physiol 1988; 255: E617-E620.
27. Dascombe MJ, Rothwell NJ, Sagay BO, Stock MJ. Pyrogenic and thermogenic effects of interleukin 1 beta in the rat. Am J Physiol 1989; 256: E7-11.
28. Leon LR. Hypothermia in systemic inflammation: role of cytokines. Front Biosci 2004; 9: 1877-1888.
29. Romanovsky AA, Almeida MC, Aronoff DM etal. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci 2005; 10: 2193-2216.
30. Roth J. Endogenous antipyretics. Clin Chim Acta 2006; 371: 13-24.
31. Rothwell NJ. Central effects of TNF alpha on thermogenesis and fever in the rat. Biosci Rep 1988; 8: 345-352.
32. Coombes RC, Rothwell NJ, Shah P, Stock MJ. Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat. Biosci Rep 1987; 7: 791-799.
33. Dinarello CA, Cannon JG, Wolff SM etal. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450.
34. Long NC, Kunkel SL, Vander AJ, Kluger MJ. Antiserum against tumor necrosis factor enhances lipopolysaccharide fever in rats. Am J Physiol 1990; 258: R332-R337.
35. Long NC, Morimoto A, Nakamori T, Murakami N. Systemic injection of TNF-alpha attenuates fever due to IL-1 beta and LPS in rats. Am J Physiol 1992; 263: R987-R991.
36. Tollner B, Roth J, Storr B, Martin D, Voigt K, Zeisberger E. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide. Pflugers Arch 2000; 440: 925-932.
37. Holt SJ, Grimble RF, York DA. Tumour necrosis factor-alpha and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system. Brain Res 1989; 497: 183-186.
38. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72: 219-246.
39. Solinas G, Karin M. JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J 2010; 24: 2596-2611.
40. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-2117.
41. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
42. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
43. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738-749.
44. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070-11075.
45. Cani PD, Amar J, Iglesias MA etal. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
46. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165.
47. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87: 507-520.
48. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. Plos Biol 2008; 6: e237.
49. Cinti S, Mitchell G, Barbatelli G etal. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
50. Medina-Gomez G, Gray SL, Yetukuri L etal. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. Plos Genet 2007; 3: e64.
51. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007; 56: 16-23.
52. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184.
53. Juge-Aubry CE, Somm E, Giusti V etal. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003; 52: 1104-1110.
54. Dayer JM, Chicheportiche R, Juge-Aubry C, Meier C. Adipose tissue has anti-inflammatory properties: focus on IL-1 receptor antagonist (IL-1Ra). Ann N Y Acad Sci 2006; 1069: 444-453.
55. Becattini B, Marone R, Zani F etal. PI3Kgamma within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance. Proc Natl Acad Sci U S A 2011; 108: E854-E863.
56. Backhed F, Ding H, Wang T etal. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101: 15718-15723.
57. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
58. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB etal. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986-1998.
59. Poggi M, Bastelica D, Gual P etal. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007; 50: 1267-1276.
60. Elinav E, Strowig T, Henao-Mejia J, Flavell RA. Regulation of the antimicrobial response by NLR proteins. Immunity 2011; 34: 665-679.
61. Schertzer JD, Tamrakar AK, Magalhaes JG etal. NOD1 activators link innate immunity to insulin resistance. Diabetes 2011; 60: 2206-2215.
62. Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol 2007; 82: 259-264.
63. Hoffman HM, Rosengren S, Boyle DL etal. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004; 364: 1779-1785.
64. Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 2008; 4: 481-489.
65. Vandanmagsar B, Youm YH, Ravussin A etal. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2010; 17: 179-188.
66. Stienstra R, van Diepen JA, Tack CJ etal. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 2011; 108: 15324-15329.
67. Henao-Mejia J, Elinav E, Jin C etal. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185.
68. Wallenius V, Wallenius K, Ahren B etal. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8: 75-79.
69. Wernstedt I, Edgley A, Berndtsson A etal. Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice. Am J Physiol Regul Integr Comp Physiol 2006; 291: R551-R557.
70. Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 2004; 287: E182-E187.
71. Chida D, Osaka T, Hashimoto O, Iwakura Y. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 2006; 55: 971-977.
72. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ. Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A 1999; 96: 7047-7052.
73. Somm E, Henrichot E, Pernin A etal. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure. Diabetes 2005; 54: 3503-3509.
74. Chida D, Hashimoto O, Kuwahara M etal. Increased fat: carbohydrate oxidation ratio in Il1ra (-/-) mice on a high-fat diet is associated with increased sympathetic tone. Diabetologia 2008; 51: 1698-1706.
75. Garcia MC, Wernstedt I, Berndtsson A etal. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 2006; 55: 1205-1213.
76. Zorrilla EP, Sanchez-Alavez M, Sugama S etal. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A 2007; 104: 11097-11102.
77. Netea MG, Joosten LA, Lewis E etal. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006; 12: 650-656.
78. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
79. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
80. Nisoli E, Briscini L, Giordano A etal. Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity. Proc Natl Acad Sci U S A 2000; 97: 8033-8038.
81. Romanatto T, Roman EA, Arruda AP etal. Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J Biol Chem 2009; 284: 36213-36222.
82. Allen TL, Matthews VB, Febbraio MA. Overcoming insulin resistance with ciliary neurotrophic factor. Handb Exp Pharmacol 2011; 203: 179-199.
83. Matthews VB, Febbraio MA. CNTF: a target therapeutic for obesity-related metabolic disease? J Mol Med (Berl) 2008; 86: 353-361.
84. Adler R, Landa KB, Manthorpe M, Varon S. Cholinergic neuronotrophic factors: intraocular distribution of trophic activity for ciliary neurons. Science 1979; 204: 1434-1436.
85. Shapiro L, Zhang XX, Rupp RG, Wolff SM, Dinarello CA. Ciliary neurotrophic factor is an endogenous pyrogen. Proc Natl Acad Sci U S A 1993; 90: 8614-8618.
86. ALS CNTF Treatment Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996; 46: 1244-1249.
87. Miller RG, Petajan JH, Bryan WW etal. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann Neurol 1996; 39: 256-260.
88. Gloaguen I, Costa P, Demartis A etal. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proc Natl Acad Sci U S A 1997; 94: 6456-6461.
89. Bluher S, Moschos S, Bullen J Jr etal. Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 2004; 53: 2787-2796.
90. Watt MJ, Dzamko N, Thomas WG etal. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 2006; 12: 541-548.
91. Kelly JF, Elias CF, Lee CE etal. Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain. Diabetes 2004; 53: 911-920.
92. Ip NY, Nye SH, Boulton TG etal. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121-1132.
93. Schuster B, Kovaleva M, Sun Y etal. Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J Biol Chem 2003; 278: 9528-9535.
94. Davis S, Aldrich TH, Valenzuela DM etal. The receptor for ciliary neurotrophic factor. Science 1991; 253: 59-63.
95. Nguyen KD, Qiu Y, Cui X etal. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011; 480: 104-108.
96. Kosteli A, Sugaru E, Haemmerle G etal. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010; 120: 3466-3479.
97. Liu J, Divoux A, Sun J etal. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009; 15: 940-945.
98. Fain JN, Ballou LR, Bahouth SW. Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat 2001; 65: 199-209.
99. Ghoshal S, Trivedi DB, Graf GA, Loftin CD. Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. J Biol Chem 2011; 286: 889-898.
100. Madsen L, Pedersen LM, Lillefosse HH etal. UCP1 induction during recruitment of brown adipocytes in white adipose tissue is dependent on cyclooxygenase activity. Plos ONE 2010; 5: e11391.
101. Vegiopoulos A, Muller-Decker K, Strzoda D etal. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 2010; 328: 1158-1161.
102. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
103. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1: 619-625.
104. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004; 10: 734-738.
105. Bence KK, Delibegovic M, Xue B etal. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 2006; 12: 917-924.
106. Cheng A, Uetani N, Simoncic PD etal. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2002; 2: 497-503.
107. Elchebly M, Payette P, Michaliszyn E etal. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999; 283: 1544-1548.
108. Briancon N, McNay DE, Maratos-Flier E, Flier JS. Combined neural inactivation of suppressor of cytokine signaling-3 and protein-tyrosine phosphatase-1B reveals additive, synergistic, and factor-specific roles in the regulation of body energy balance. Diabetes 2010; 59: 3074-3084.
109. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 2008; 283: 14230-14241.
110. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Hypothalamic CD. IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008; 135: 61-73.
111. Kleinridders A, Schenten D, Konner AC etal. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009; 10: 249-259.
112. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006; 2006: re13.
113. Ozcan L, Ergin AS, Lu A etal. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 2009; 9: 35-51.
114. Chiang SH, Bazuine M, Lumeng CN etal. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 2009; 138: 961-975.
115. Scheja L, Heese B, Seedorf K. Beneficial effects of IKKepsilon-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice. Biochem Biophys Res Commun 2011; 407: 288-294.
116. Karin M, Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005; 57: 283-295.
117. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A 2006; 103: 10741-10746.
118. Hirosumi J, Tuncman G, Chang L etal. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-336.
119. Solinas G, Vilcu C, Neels JG etal. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007; 6: 386-397.
120. Sabio G, Cavanagh-Kyros J, Barrett T etal. Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes Dev 2010; 24: 256-264.
121. Bost F, Aouadi M, Caron L etal. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 2005; 54: 402-411.
122. Jager J, Corcelle V, Gremeaux T etal. Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia 2011; 54: 180-189.
123. Sumara G, Formentini I, Collins S etal. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 2009; 136: 235-248.
124. Nakamura T, Furuhashi M, Li P etal. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 2010; 140: 338-348.
125. Jia S, Liu Z, Zhang S etal. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008; 454: 776-779.
126. Ciraolo E, Iezzi M, Marone R etal. Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 2008; 1: ra3.
127. Foukas LC, Claret M, Pearce W etal. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 2006; 441: 366-370.
128. Hirsch E, Katanaev VL, Garlanda C etal. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000; 287: 1049-1053.
129. Quignard JF, Mironneau J, Carricaburu V etal. Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J Biol Chem 2001; 276: 32545-32551.
130. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, Rockman HA. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem 2001; 276: 18953-18959.
131. Vecchione C, Patrucco E, Marino G etal. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J Exp Med 2005; 201: 1217-1228.
132. Crackower MA, Oudit GY, Kozieradzki I etal. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002; 110: 737-749.
133. Patrucco E, Notte A, Barberis L etal. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 2004; 118: 375-387.
134. Kobayashi N, Ueki K, Okazaki Y etal. Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance. Proc Natl Acad Sci U S A 2011; 14: 5753-5758.
135. Ortega-Molina A, Efeyan A, Lopez-Guadamillas E etal. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab 2012; 15: 382-394.
136. Arruda AP, Milanski M, Velloso LA. Hypothalamic inflammation and thermogenesis: the brown adipose tissue connection. J Bioenerg Biomembr 2011; 43: 53-58.
137. Konner AC, Bruning JC. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab 2011; 22: 16-23.
138. Ettinger MP, Littlejohn TW, Schwartz SL etal. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA 2003; 289: 1826-1832.
139. Kim MS, Lee MS, Kown DY. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals. Ann N Y Acad Sci 2011; 1229: 140-146.
140. Dulloo AG. The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Obes Rev 2011; 12: 866-883.
141. Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A 2006; 108: E854-E863.
142. Jaeschke A, Davis RJ. Metabolic stress signaling mediated by mixed-lineage kinases. Mol Cell 2007; 27: 498-508.
143. Holzer RG, Park EJ, Li N etal. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 2011; 147: 173-184.
144. Oh DY, Talukdar S, Bae EJ etal. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687-698.
145. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008; 134: 933-944.